Possible beneficial effect of telmisartan on glycemic control in diabetic subjects

被引:45
作者
Honjo, S
Nichi, Y
Wada, Y
Hamamoto, Y
Koshiyama, H
机构
[1] Kitano Hosp, Tazuke Kofukai Med Res Inst, Ctr Diabet & Endocrinol, Osaka 5308480, Japan
[2] Grad Sch Med, Dept Diabet & Clin Nutr, Kyoto, Japan
关键词
D O I
10.2337/diacare.28.2.498
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:498 / 498
页数:1
相关论文
共 3 条
[1]   Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity [J].
Benson, SC ;
Pershadsingh, HA ;
Ho, CI ;
Chittiboyina, A ;
Desai, P ;
Pravenec, M ;
Qi, NN ;
Wang, JM ;
Avery, MA ;
Kurtz, TW .
HYPERTENSION, 2004, 43 (05) :993-1002
[2]   Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study [J].
Derosa, G ;
Ragonesi, PD ;
Mugellini, A ;
Ciccarelli, L ;
Fogari, R .
HYPERTENSION RESEARCH, 2004, 27 (07) :457-464
[3]   Insulin-sensitizing effects of telmisartan [J].
Pershadsingh, HA ;
Kurtz, TW .
DIABETES CARE, 2004, 27 (04) :1015-1015